Frankfurt - Delayed Quote EUR
Gyre Therapeutics, Inc. (L9S.F)
8.00
0.00
(0.00%)
As of 8:01:27 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| EASTLING THOMAS WILSON Director | Conversion of Exercise of derivative security | Apr 16, 2025 | 15,000 |
| MA SONGJIANG President | Sale | Mar 21, 2025 | -- |
| USMAN NASSIM Director | Conversion of Exercise of derivative security | Jun 28, 2024 | 2,276 |
Related Tickers
ATQP.SG Vericel Corp
35.00
-1.69%
87S.BE Roivant Sciences Ltd
9.60
+3.16%
6XC.BE Soleno Therapeutics Inc
64.40
0.00%
CXF.F Chimerix, Inc.
7.48
0.00%
41X.SG Ardelyx Inc
4.5490
+5.03%
DR6.DU ACADIA Pharmaceuticals Inc
12.88
-0.35%
1JK.SG Apellis Pharmaceuticals Inc
15.41
+0.21%
87S.MU Roivant Sciences Ltd
9.59
+3.05%
YDO1.BE Madrigal Pharmaceuticals Inc
280.00
+4.32%
ATQP.F Vericel Corporation
36.20
+4.02%